Sunday, May 8, 2016

Immunohistochemistry for NF2, LATS1/2, and YAP/TAZ Fails to Separate Benign From Malignant Mesothelial Proliferations

Brandon S. Sheffield MD1Julie Lorette MLT2Yaoqing Shen MD3Marco A. Marra PhD3,4Andrew Churg MD1,5
1 Departments of Pathology and Laboratory Medicine and
4 Medical Genetics, University of British Columbia, Vancouver, Canada;
2 Department of Pathology and
3 Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, Canada;
5 Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada

1 comment:

  1. Thanks for making the effort to describe the terminlogy to the beginners!
    water bath manufacturers

    ReplyDelete